Bridgecreek Investment Management’s AbbVie ABBV Stock Holding History

Bridgecreek Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$1.51M	Sell	9,728 -1,750	-15%	-$255K	0.29%	53
2023 Q3	$1.71M	Buy	11,478 +28	+0.2%	+$4.11K	0.35%	54
2023 Q2	$1.54M	Sell	11,450 -25	-0.2%	-$3.67K	0.3%	58
2023 Q1	$1.83M	Hold	11,475	–	–	0.38%	54
2022 Q4	$1.85M	Sell	11,475 -4,875	-30%	-$747K	0.41%	52
2022 Q3	$2.19M	Buy	16,350 +1,350	+9%	+$194K	0.47%	54
2022 Q2	$2.3M	Buy	15,000 +585	+4%	+$89.4K	0.48%	52
2022 Q1	$2.34M	Buy	+14,415	New	+$2.09M	0.35%	65

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bridgecreek Investment Management's ABBV Position: Q4 2023 in Review

Bridgecreek Investment Management reduced its AbbVie (ABBV) stake by 15% in Q4 2023, selling an estimated $255K and leaving 9,728 shares worth $1.51M. The position accounts for 0.29% of the portfolio, ranked #53.

Bridgecreek Investment Management first reported a position in ABBV in Q1 2022 and has held it in 8 quarters since. The position peaked at $2.34M in Q1 2022. 3,323 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.

Bridgecreek Investment Management held 9,728 shares of AbbVie worth $1.51M as of Q4 2023.
Bridgecreek Investment Management sold 1,750 AbbVie shares in Q4 2023, an estimated $255K.
AbbVie made up 0.29% of Bridgecreek Investment Management's portfolio in Q4 2023, its #53 holding.
Bridgecreek Investment Management first reported a position in AbbVie in Q1 2022 and has held it in 8 quarters since.
Bridgecreek Investment Management's AbbVie position peaked at $2.34M in Q1 2022.
3,323 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.

Based on Bridgecreek Investment Management's 13F filing for Q4 2023, filed 13 Feb 2024.